N
CODX

Nuveen’s Co-Diagnostics CODX Stock Holding History

Nuveen’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-26,397
Closed -$7.55M – 3398
2021
Q1 		$7.55M Buy
26,397
+3,278
+14% +$1.31M ﹤0.01% 1947
2020
Q4 		$6.45M Buy
23,119
+1,523
+7% +$564K ﹤0.01% 1936
2020
Q3 		$8.8M Buy
21,596
+14,179
+191% +$7.28M ﹤0.01% 1601
2020
Q2 		$4.3M Buy
+7,417
New +$3.39M ﹤0.01% 1978

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nuveen's CODX Position: Q2 2021 in Review

Nuveen sold out of Co-Diagnostics (CODX) in Q2 2021, closing a stake of 26,397 shares — an estimated $7.55M sold.

Nuveen first reported a position in CODX in Q2 2020 and held it in 4 quarters. The position peaked at $8.8M in Q3 2020. 88 funds tracked by Wall St. Rank hold CODX as of Q2 2021.

  • Nuveen reported no remaining Co-Diagnostics position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 26,397 Co-Diagnostics shares in Q2 2021, an estimated $7.55M.
  • Nuveen first reported a position in Co-Diagnostics in Q2 2020 and held it in 4 quarters.
  • Nuveen's Co-Diagnostics position peaked at $8.8M in Q3 2020.
  • 88 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.